M
Maze Therapeutics, Inc.
MAZE · NASDAQ · Healthcare · 1.5B
Closing price
$27.11
+4.75% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
3.3×
Enterprise value / EBITDAEV/EBITDA
-7.8×
Free cash flow yieldFCF yield
-9.7%
Return on equityROE
-36.9%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
1.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.